14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

BioMarin Pharmaceutical Inc. Stock Forecast

NASDAQ:BMRN BUY SELL

$79.28 (1.41%)

Volume: 852.209k

Closed: May 19, 2022

Hollow Logo Score: -0.469

BioMarin Pharmaceutical Inc. Stock Forecast

BUY SELL NASDAQ:BMRN
$79.28 (1.41%)

Volume: 852.209k

Closed: May 19, 2022

Score Hollow Logo -0.469

BioMarin Pharmaceutical Inc. Stock Forecast NASDAQ:BMRN

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-04-25 42.53% Morgan Stanley $96.00 $113.00 Upgrades Equal-Weight Overweight
2022-04-12 21.09% Morgan Stanley $90.00 $96.00 Maintains Equal-Weight
2022-02-24 57.67% Piper Sandler $121.00 $125.00 Maintains Overweight
2021-11-22 32.44% Credit Suisse $100.00 $105.00 Maintains Outperform
2021-11-22 45.06% SVB Leerink $112.00 $115.00 Maintains Outperform
2021-11-22 13.52% Morgan Stanley $82.00 $90.00 Maintains Equal-Weight
2021-11-22 - William Blair - Upgrades Market Perform Outperform
2021-11-15 41.27% SVB Leerink $108.00 $112.00 Maintains Outperform
2021-10-28 26.14% Credit Suisse $102.00 $100.00 Maintains Outperform
2021-09-09 21.09% Stifel $86.00 $96.00 Upgrades Hold Buy
2021-07-29 11% RBC Capital $87.00 $88.00 Maintains Sector Perform
2021-04-19 3.43% Morgan Stanley $85.00 $82.00 Maintains Equal-Weight
2021-03-01 14.78% Canaccord Genuity $95.00 $91.00 Maintains Buy
2021-03-01 26.14% Evercore ISI Group $90.00 $100.00 Upgrades In-Line Outperform
2020-11-06 36.23% SVB Leerink $113.00 $108.00 Reiterates Outperform
2020-09-10 57.67% Truist Securities $130.00 $125.00 Maintains Buy
2020-08-21 7.21% Morgan Stanley $125.00 $85.00 Maintains Equal-Weight
2020-08-20 - William Blair - Downgrades Outperform Market Perform
2020-08-20 19.83% Canaccord Genuity $119.00 $95.00 Maintains Buy
2020-08-20 16.04% RBC Capital $123.00 $92.00 Downgrades Outperform Sector Perform
2020-08-20 8.48% Citigroup $148.00 $86.00 Downgrades Buy Neutral
2020-08-19 26.14% Stifel $127.00 $100.00 Downgrades Buy Hold
2020-08-19 42.53% SVB Leerink $140.00 $113.00 Maintains Outperform
2020-08-06 36.23% BMO Capital $94.00 $108.00 Maintains Market Perform
2020-08-05 76.59% SVB Leerink $130.00 $140.00 Maintains Outperform
2020-07-08 57.67% Morgan Stanley $125.00 Downgrades Overweight Equal-Weight
2020-06-18 80.37% SunTrust Robinson Humphrey $109.00 $143.00 Maintains Buy
2020-06-18 19.83% Oppenheimer $88.00 $95.00 Maintains Perform
2020-06-10 63.98% B of A Securities $120.00 $130.00 Maintains Buy
2020-04-30 37.49% SunTrust Robinson Humphrey $110.00 $109.00 Maintains Buy
2020-04-30 61.45% Credit Suisse $131.00 $128.00 Maintains Outperform
2020-03-03 57.67% Morgan Stanley $120.00 $125.00 Maintains Overweight
2020-03-02 106.86% Wedbush $175.00 $164.00 Maintains Outperform
2020-01-28 18.57% BMO Capital $94.00 Initiates Coverage On Market Perform
2020-01-24 - RBC Capital - Upgrades Sector Perform Sector Outperform
2019-11-27 23.61% Barclays $98.00 Upgrades Equal-Weight Overweight
2019-11-12 38.75% SunTrust Robinson Humphrey $110.00 Initiates Coverage On Buy
2019-10-30 19.83% Citigroup $120.00 $95.00 Maintains Buy
2019-10-28 36.23% Canaccord Genuity $117.00 $108.00 Maintains Buy
2019-10-25 91.73% Wedbush $128.00 $152.00 Maintains Outperform
2019-10-24 8.48% Barclays $95.00 $86.00 Maintains Equal-Weight
2019-10-24 -2.88% Nomura $93.00 $77.00 Maintains Neutral
2019-10-17 13.52% B of A Securities $90.00 Reinstates Buy

BMRN Stock Trend

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected.

Given the current horizontal trend, you can expect BioMarin Pharmaceutical Inc. stock with a 90% probability to be traded between $76.14 and $88.27 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Data

Date Bottom Mid Top
2022-05-23 $74.84 $80.80 $86.76
2022-05-24 $74.87 $80.82 $86.78
2022-05-25 $74.89 $80.85 $86.81
2022-05-26 $74.92 $80.87 $86.83
2022-05-27 $74.94 $80.90 $86.86
2022-05-31 $74.97 $80.92 $86.88
2022-06-01 $74.99 $80.95 $86.91
2022-06-02 $75.02 $80.97 $86.93
2022-06-03 $75.04 $81.00 $86.96
2022-06-06 $75.07 $81.02 $86.98
2022-06-07 $75.09 $81.05 $87.00
2022-06-08 $75.11 $81.07 $87.03
2022-06-09 $75.14 $81.10 $87.05
2022-06-10 $75.16 $81.12 $87.08
2022-06-13 $75.19 $81.15 $87.10
2022-06-14 $75.21 $81.17 $87.13
2022-06-15 $75.24 $81.20 $87.15
2022-06-16 $75.26 $81.22 $87.18
2022-06-17 $75.29 $81.25 $87.20
2022-06-21 $75.31 $81.27 $87.23
2022-06-22 $75.34 $81.29 $87.25
2022-06-23 $75.36 $81.32 $87.28
2022-06-24 $75.39 $81.34 $87.30
2022-06-27 $75.41 $81.37 $87.33
2022-06-28 $75.44 $81.39 $87.35
2022-06-29 $75.46 $81.42 $87.38
2022-06-30 $75.49 $81.44 $87.40
2022-07-01 $75.51 $81.47 $87.43
2022-07-05 $75.54 $81.49 $87.45
2022-07-06 $75.56 $81.52 $87.47

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of MPS IV A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with mucopolysaccharidosis VI; Kuvan, a proprietary syn... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT